✦ LIBER ✦

Remission induction in children with acute non-lymphocytic leukemia using cytosine arabinoside and doxorubicin or daunorubicin: A report from the childrens cancer study group

✍ Scribed by Buckley, Jonathan D. ;Lampkin, Beatrice C. ;Nesbit, Mark E. ;Bernstein, Irwin D. ;Feig, Stephen A. ;Kersey, John H. ;Piomelli, Sergio ;Kim, Tae ;Hammond, G. Denman

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 874 KB
Volume: 17
Category: Article
ISSN: 0098-1532
DOI: 10.1002/mpo.2950170507

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prolonged second remissions in childhood

Prolonged second remissions in childhood acute lymphocytic leukemia: A report from the childrens cancer study group

✍ Baum, E. ;Nachman, J. ;Ramsay, N. ;Weetman, B. ;Neerhout, R. ;Littman, P. ;Griff 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 519 KB

To date, median duration of second and subsequent remissions in childhood acute lymphocytic leukemia (ALL) has been short, with most studies reporting median remission duration less than 6 months. In May 1979, the Childrens Cancer Study Group (CCSG) undertook a pilot study to assess the efficacy of

Evaluation of cyclocytidine in reinducti

Evaluation of cyclocytidine in reinduction and maintenance therapy of children with acute nonlymphocytic leukemia previously treated with cytosine arabinoside: A report from children's cancer study group

✍ Movassaghi, Nasser ;Higgins, Gussie ;Pyesmany, Allan ;Baehner, Robert ;Chard, Ro 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB

A study of children in relapse with acute nonlymphocytic leukemia (ANLL) previously maintained in remission with combination chemotherapy including cytosine arabinoside (Ara-C) was undertaken by Children's Cancer Study Group (CCSG) to assess the efficacy of cyclocytidine (Cyclo-C), a depot Ara-C, co

Improvement in outcome for children with

Improvement in outcome for children with acute nonlymphocytic leukemia. A report from the childrens cancer study group

✍ Jonathan D. Buckley; Ronald L. Chard; Robert L. Baehner; Mark E. Nesbit; Beatric 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 888 KB

The Childrens Cancer Study Group conducted four therapeutic studies on a total of 1006 children with acute nonlymphocytic leukemia from 1972 to 1983. This report describes the therapeutic strategies of these studies and examines trends in induction rates and long-term outcome over this period. The r

Successful reinduction therapy with amsa

Successful reinduction therapy with amsacrine and cyclocytidine in acute nonlymphoblastic leukemia in children. A report from the childrens cancer study group

✍ Linda P. Miller; Allan F. Pyesmany; Lawrence J. Wolff; Paul C. J. Rogers; Stuart 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB

Amsacrine (AMSA) and cyclocytidine were studied as retrieval therapy in 122 pediatric patients with acute nonlymphoblastic leukemia (ANLL). Patients either failed to achieve sustained initial remissions or were in relapse. Induction therapy consisted of intravenous (IV) AMSA (75 mg/mz) from days 1 t

A phase I study of carboplatin in childr

A phase I study of carboplatin in children with acute leukemia in bone marrow relapse: A report from the childrens cancer group

✍ Lawrence J. Ettinger; Mark D. Krailo; Paul S. Gaynon; G. Denman Hammond 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 576 KB

Treatment of high-risk acute lymphoblast

Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: A report from the Kyushu-Yamaguchi children cancer study group in Japan

✍ Matsuzaki, Akinobu; Ishii, Eiichi; Okamura, Jun; Eguchi, Haruhiko; Yoshida, Nobu 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 770 KB

A total of 125 children, who were diagnosed as having high-risk acute lymphoblastic leukemia (ALL), were treated with two consecutive protocols designated as AL851 (1985( -1988( ) and ALHR88 (1988( -1990)). All patients received induction therapy consisting of vincristine (VCR), prednisolone (PSL),